26
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Concerns and Needs for Research in Herbal Supplement Pharmacotherapy and Safety

(Associate Professor of Pharmacology and Toxicology)
Pages 3-23 | Received 06 Jan 2000, Accepted 17 Mar 2000, Published online: 20 Aug 2009

References

  • Grund J. The societal value of pharmaceuticals. Balancing industrial and healthcare policy. Pharmacoeconomics 1996; 10: 14–22
  • McKercher P. L. Pharmaceutical research and development. Clin Therapeut 1992; 14: 760–764
  • Alberts A. W. Lovastatin and simvastatin-inhibitors of HMG CoA reductase and cholesterol biosynthesis. Cardiology 1990; 77S: 14–21
  • Wall M. E., Wani M. C. Camptothecin and taxol: from discovery to clinic. J Ethnopharmacol 1996; 51: 239–253
  • Perry E. K., Pickering A. T., Wang W. W., Houghton P. J., Perry N. S. Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy. J Pharm Pharmacol 1999; 51: 527–534
  • McKenna D. J. Plant hallucinogens: springboards for psychotherapeutic drug discovery. Behav Brain Res 1996; 73: 109–116
  • Goerig M., Esch J. S. Friedrich Wilhelm Adam Serturner-on the 150th anniversary of the death of the discoverer of morphine. Anasthesiol Intesnsivmed Notfallmed Schmertzther 1991; 26: 492–498
  • Manasse H. R., Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy. Part I. Am J Hosp Pharm 1989; 46: 929–944
  • Lazarou J., Pomerantz B. H., Corey P. N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–1205
  • Scott B. Medication errors rank as a top patient worry in hospitals, health systems: new survey reveals patients more concerned with receiving wrong medication than with pain or costs. American Society of Health-System Pharmacists: press release, 9/13/99
  • Leape L. L., Cullen D. J., Clapp M. D., Burdick E., Demonaco H. J., Erickson J. I., Bates D. W. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282: 267–270
  • Kucukarslan S., Hakim Z., Sullivan D., Taylor S., Grauer D., Haughtvedt C., Zgarrick D. Points to consider about prescription drug prices: an overview of federal policy and pricing studies. Clin Therapeut 1993; 15: 726–738
  • Novak V. The other drug lords. Int J Health Serv 1993; 23: 263–273
  • Merrill R. A. Modernizing the FDA: an incremental revolution. Health Aff 1999; 18: 96–111
  • Meyer U. A., Zanger U. M. Molecular mechanisms of genetic polymorphisms of drug metabolism. Ann Rev Pharmacol Toxicol 1997; 37: 269–296
  • Johnston B. A. One-third of nation's adults use herbal remedies:market estimated at $3.24 billion. HerbalGram 1997; 40: 49
  • Eisenberg D. M., Kessler R. C., Foster C., Norlock F. E., Calkins D. R., Delbanco T. L. Unconventional medicine in the United States: prevalence, costs and patterns of use. New Engl J Med 1993; 328: 246–252
  • LeBars P. L., Katz M. M., Berman N., Itil T. M., Freedman A. M., Schatzberg A. F. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 1997; 278: 1327–1332
  • Linde K., Ramierez G., Mulrow C. D., Pauls A., Weidenhammer W., Melchart D. St. John's wort for depression-an overview and meta-analysis of randomized clinical trials. Brit Med J 1996; 313: 253–258
  • Koscielny J., Klussendorf D., Latza R., Schmitt R., Radtke H., Siegel G., Kiesewetter H. The antiatherosclerotic effect of Allium sativum. Atherosclerosis 1999; 144: 237–249
  • Newall C. A., Anderson L. A., Phillipson J. D. Herbal Medicines: A Guide for Health-Care Professionals. Pharmaceutical Press, London 1996
  • Miller L. G., Murray W. J. Herbal Medicinals: A Clinician's Guide. Pharmaceutical Products Press, New York, NY 1998
  • Bratman S., Kroll D. J. Natural Health Bible. Prima Publishing, Rocklin, CA 1999
  • Bratman S., Kroll D. J. Clinical Evaluation of Medicinal Herbs and Other Therapeutic Natural Products. Prima Publishing, Rocklin, CA 1999
  • DeSmet P. A. Health risks of herbal remedies. Drug Saf 1995; 13: 81–93
  • DeSmet P. A., Brouwers J. R. Pharmacokinetic evaluation of herbal remedies: basic introduction, applicability, current status, and regulatory needs. Clin Pharmacokinet 1997; 32: 427–436
  • Drew A. K., Meyers S. P. Safety issues in herbal medicines: implications for the health professions. Med J Aust 1997; 166: 538–541
  • Miller L. G. Herbal medicinals: selected clinical consideration focusing on known or potential drug-herb interactions. Arch Intern Med 1998; 158: 2200–2211
  • Cupp M. J. Herbal remedies: adverse effects and drug interactions. Am Fam Physician 1999; 59: 1239–1245
  • Lantz M. S., Buchalter E., Giambanco V. St. John's wort and antidepres-sant drug interactions in the elderly. J Geriatr Psychiatry Neurol 1999; 12: 7–10
  • Rosenblatt M., Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. New Engl J Med 1997; 336: 1108
  • McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J 1996; 155: 293–295
  • Nebel A., Schnieder B. J., Baker R. K., Kroll D. J. Potential metabolic interaction between St. John's wort and theophylline. Ann Pharmacother 1999; 33: 502
  • Gillis C. N. Panax ginseng pharmacology: a nitric oxide link?. Biochem Pharmacol 1997; 54: 1–8
  • Goldenberg M. M. Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction. Clin Ther 1998; 20: 1033–1048
  • Winslow L. C., Kroll D. J. Herbs as medicines. Arch Intern Med 1998; 158: 2192–2199
  • Angell M., Kassirer J. P. Alternative medicine: the risks of untested and unregulated remedies. New Engl J Med 1998; 339: 839–841
  • Cairns T., Siegmund E. G., Rader B. R. Identification of prescription drugs in adulterated Chinese herbal medicines. Pharmaceut Res 1986; 4: 126–129
  • Kew J., Morris C., Aihie A., Fysh R., Jones S., Brooks D. Arsenic and mercury intoxication due to Indian ethnic remedies. Brit Med J 1993; 306: 506–507
  • Ries C. A., Sahud M. A. Agranulocytosis caused by Chinese herbal medicines. Dangers of medications containing aminopyrine and phenylbutazone. JAMA 1975; 231: 352–355
  • Schaumberg H. H., Berger A. Alopeica and sensory neuropathy from thallium in a Chinese herbal medication. JAMA 1992; 268: 3430–3431
  • Shaw D., Leon C., Kolev S., Murray V. Traditional remedies and food supplements. A 5-year toxicological study (1991–1995). Drug Saf 1997; 17: 342–356
  • Wu M. S., Jong J. J., Lin J. L., Yang C. W., Chien H. C. Multiple tubular dysfunction induced by mixed Chinese herbal medicines containing cadmium. Neph-rol Dial Transplant 1996; 11: 867–870
  • Cui J., Garle M., Eneroth P., Bjorkhem I. What do commercial ginseng preparations contain?. Lancet 1994; 344: 134
  • Stewart K. Denver lab detects samples of fabricated St. John's wort. Natural Foods Merchandiser Nov., 1997; 1
  • Gulick R. M., McAuliffe V., Holden-Wiltse J., Crumpacker C., Liebes L., Stein D. S., Meehan P., Hussey S., Forcht J., Valentine F. T. Phase I studies of hypericin, the active compound in St. John's wort, as an antiretroviral agent in HIV-infected adults. Ann Intern Med 1999; 130: 510–514
  • Golightly L. K., Smolinske S. S., Bennett M. L., Sutherland E. W., 3rd, Rumack B. H. Pharmaceutical excipients. Adverse effects associated with ingredients in drug products (Part I). Med Toxicol Adverse Drug Exp 1988; 3: 128–165
  • Lo A. C., Chan K., Yeung J. H., Woo K. S. Danggui (Angelica sinsensis) affects the pharmcodynamics but not the pharmacokinetics of warfarin in rabbits. Eur J Drug Metab Pharmacokinet 1995; 20: 55–60
  • Page R. L., 2nd, Lawrence J. D. Potentiation of warfarin by dong quai. Pharmacotherapy 1999; 19: 870–876
  • Wells P. S., Holbrook A. M., Crowther N. R., Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994; 121: 676–683
  • Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 1998; 352: 36
  • Strauss L., Santti R., Saarinen N., Streng T., Joshi S., Makela S. Dietary phytoestrogens and their role in hormonally dependent disease. Toxicol Lett 1998; 102–103: 349–354
  • Stoll B. A. Eating to beat breast cancer: potential role for soy supplements. Annals of Oncology 1997; 8: 223–225
  • McMichael-Phillips D. F., Harding C., Morton M., Roberts S. A., Howell A., Potten C. S., Bundred N. J. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Amer J Clin Nutr 1998; 68: 1431S–1435S
  • Hsieh C. Y., Santell R. C., Haslam S. Z., Helferich W. G. Estrogenic effects of genistein on the growth of estrogen receptor postive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1999; 58: 3833–3838
  • Schulz H., Schurer M., Krumbiegel G., Wachter W., Weyenmeyer R., Seidel G. Untersuchungen zum Freisetzungverhalten und zer Bioaequivalence von Silymarin-praeparaten [The solubility and bioequivalence of silymarin preparations]. Arzneimittel Forschung 1995; 45: 61–64
  • Hansten P. D., Horn J. R., Koda-Kimble M. A. Drug interactions and updates. Lea & Febiger, Vancouver, WA 1993
  • Lewis D. F., Watson E., Lake B. G. Evolution of the cytochrome P450 superfamily: sequence alignments and pharmacogenetics. Mutation Res 1998; 410: 245–270
  • Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W. P450 superfamily: update on new sequences, gene mapping, accession numbers, and nomeclature. Pharmacogenetics 1996; 6: 1–42
  • Lehmann J. M., McKee D. D., Watson M. A., Willson T. M., Moore J. T., Kliewer S. A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998; 102: 1016–1023
  • Ogbru O. Drug interactions with grapefruit juice. Drug Link News Letter. Facts and Comparisons, St. Louis, MO 1997; 59–61
  • Piscitelli S. C., Burstein A. H., Chaitt D., Alfaro R. M., Falloon J. Indi-navir concentrations and St. John's wort. Lancet 2000; 355: 547–548
  • Ruschitzka F., Meier P. J., Turina M., Luscher T. F., Noll G. Acute heart transplant rejection due to Saint John's wort. Lancet 2000; 355: 548–549
  • Johne A., Brockmoller J., Bauer S., Maurer A., Langheinrich M., Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort extract (Hypericum perforatum). Clin Pharmacol Ther 1999; 66: 338–345
  • Kim R. B., et al. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharm Res 1999; 16: 408–414
  • Markovitz J. S., DeVane C. L., Boulton D. W., Carson S. W., Nahas Z., Risch S. C. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sci 2000; 66: 133–139
  • Angell M., others. Alternative medicine-the case of herbal remedies. New Engl J Med 1999; 340: 564–566
  • Miller L. G., Murray W. J. Herbal instruction in United States pharmacy schools. Amer J Pharmaceut Edu 1997; 61: 160–162
  • Rowell D. M., Kroll D. J. Complementary and alternative medicine education in United States pharmacy schools. Amer J Pharmaceut Edu 1998; 62: 412–419
  • Wetzel M. S., Eisenberg D. M., Kaptchuk T. J. Courses involving complementary and alternative medicine at U.S. medical schools. JAMA 1998; 280: 784–787
  • Dossey L. ‘You people’: intolerance and alternative medicine. Alternative Therapies 1999; 5: 12–17; 109–112
  • DerMarderosian A. H. Natural medicine. American Druggist Nov., 1994
  • Astin J. A. Why patients use alternative medicine: results of a national study. JAMA 1998; 279: 1548–1553
  • O'Hara M., Kiefer D., Farrell K., Kemper K. A review of 12 commonly used medicinal herbs. Arch Fam Med 1998; 7: 523–536
  • Berthold H. K., Sudhop T., von Bergmann K. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial. JAMA 1998; 279: 1900–1902
  • Agarwal K. C. Therapeutic actions of garlic constituents. Med Res Rev 1996; 16: 111–124
  • Brewer T., Colditz G. A. Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA 1999; 281: 824–829

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.